zevra_inline_fullcolor_rgb_12in@300ppi (1).png
Zevra Therapeutics to Report Second Quarter 2024 Financial Results
30 juil. 2024 08h38 HE | Zevra Therapeutics
CELEBRATION, Fla., July 30, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company) a rare disease therapeutics company, today announced that it will host a...